Meningitis is defined as an inflammation of the membranes and cerebrospinal fluid that encases and bathes the brain and spinal cord. It is a serious disease which can be life-threatening and may result in permanent complications if not diagnosed and treated early. The pathogenic development of the disease suggests that meningitis can be broadly categorized into three main types [
1].
Bacterial meningitis, which is rare, but more serious and can be life-threatening if not treated immediately.
Fungal meningitis is typically diagnosed in patients with pre-existing conditions that have a weakened immune system, such as those living with lupus or HIV.
Viral meningitis is caused by a virus (can be acute or chronic), is more common, but is far less serious and those who are diagnosed usually make a full recovery.
Symptoms of meningitis amongst children can appear very quickly or may take several days to make themselves known and include: fever; irritability; headache; photophobia (eye sensitivity to light); stiff neck; skin rashes; jaundice; inability to feed; high pitched cry; lethargy; seizures. Early diagnosis and timely interventions are the most effective ways for preventing negative outcomes associated with the disease.
Whilst meningitis cases affect all age demographics, the World Health Organisation has observed the highest rates of infection in young children [
2]. For example, bacterial meningitis predominantly affects younger children and most cases of viral meningitis occur in children under the age of five years [
3]. Epidemiological studies suggest rates of about two to ten cases per 10,000 live births with children particularly vulnerable to meningitis between the ages of 3 months and 3 years [
4]. Fatality rates vary from as low as 2% for infants to 20 - 30% for neonates and adults. Since the mid-1980s, as a result of the protection offered by current vaccines and an increased understanding of the mechanisms of the disease [
5], the median age at which bacterial meningitis is diagnosed has shifted from 15 months to 25 years. Geographically, meningitis epidemics have been experienced in various parts of the world, with research suggesting that climate might be a contributory risk factor in the spread of the disease [
6].
In addition to the symptomatic development and epidemiological spread of the disease, there are other known risk factors associated with meningitis which include social, environmental and economic determinants. Although most cases are isolated, the disease can spread amongst people living in close social proximity, and outbreaks have occurred in those areas where there is a higher degree of social interaction or in areas experiencing overcrowding [
7] which promotes exposure and transmission. The research indicates that meningitis in more prevalent in poorer areas then in affluent areas, suggesting that there is also a strong socio-economic component to the development of the disease [
8]. Indeed the risk of invasive meningococcal disease (leading cause of bacterial meningitis) in children is strongly influenced by unfavorable socioeconomic conditions [
9]. Increased levels of poverty are also linked to identified barriers in terms of geography, income, and socio-cultural differences. Research has found that presenting for treatment and early management of the disease is compounded by issues related to geography (access to medical facility), income (cost of healthcare), or cultural differences (attitudes towards illness and disease) which prevent lower socio-economic groups from receiving treatment, increasing the risk of adverse outcomes. Others have suggested that improvements in access to healthcare and earlier treatment are more likely to reduce the rate of mortality from meningitis [
10].
Physicians are confronted with a broad range of symptoms and risk factors which they need to take into account when assessing a patient with possible meningitis, and when establishing the consequences of various treatment options. The ways in which these symptoms and risk factors inter-relate and how they are identified by healthcare professionals are integral to improving outcomes from the disease.
At a macro level, a number of studies have shown that the diagnosis and treatment management of meningitis is a complex and challenging problem for government and healthcare agencies requiring novel approaches to its management and intervention [
11-
14]. This has involved the application of modelling approaches for diagnosis and treatment. Public health experts working at the health protection agencies have developed a model to determine if suspected meningitis is bacterial or viral in origin. Clinical prediction rules have also been used to develop bacterial meningitis scores that classify patients according to risk of contraction [
15]. Some diagnostic decision rules for management of children with meningeal signs have also been proposed to assist in timely diagnosis and decision-making [
13,
16]. Diagnostic scores have been constructed to predict disease outcomes and have been applied to successfully identify at-risk patients [
17,
18]. Based on literature studies, the symptoms, clinical features and microbiological (lab) examinations are the principal factors contributing to the accurate diagnosis and risk assessment of meningitis.
In this paper, we are proposing a modelling approach to understanding meningitis which focuses on capturing the various symptoms associated with the disease, incorporating specific risk factors such as socio-economic determinants as derived from expert knowledge provided by physicians. This work models the complex problem of meningitis diagnosis and severity assessment using Fuzzy cognitive mapping (FCM), which is an effective knowledge representation and modelling technique [
19]. Through the proposed technique, the paper will develop and validate a simple tool to predict the likelihood of viral or bacterial meningitis in younger infants and children.
The main scope of this work is the construction of a knowledge based tool for modelling meningitis diagnosis for children living in semi-urban areas of India. The meningitis diagnostic procedure typically involves close interaction between the biologist, pathologist and the paediatrician and involves extracting and analyzing blood samples from the patient. The diagnosis of meningitis is more challenging within semi-urban areas of Indian cities given the lack of healthcare infrastructure, co-ordination between healthcare agencies and professionals and the shortage of qualified physicians which potentially delay identification of the disease. Moreover, the average costs of laboratory tests and potentially long hospital stays as a result, make treatment expensive and unaffordable for the majority of patients living within developing countries [
20].
A decision-making tool to assist in the diagnosis of meningitis provides the potential for healthcare professionals to arrive at a decision sooner and alleviates the cost burden to the patient if laboratory tests and hospital stays are not required. No previous research has explored FCM methodology for assessing and diagnosing meningitis. The tool proposed in this research is designed to aid paediatricians who are responsible for clinical decision-making regarding the treatment of children with meningitis which involves: diagnosing the disease and its severity and making decisions regarding the most appropriate treatment.
This paper is structured into five sections. The section on Methods briefly describes the principal aspects of FCM formalization and describes the construction of a tool to support the diagnosis of meningitis. The Results describes the accuracy of the tool in predicting the diagnosis of meningitis. Finally the Discussion and Conclusions emerging from the study are presented.